Index
1 Influenza Drugs Market Overview
1.1 Influenza Drugs Product Overview
1.2 Influenza Drugs Market Segment by Type
1.2.1 Zanamivir
1.2.2 Oseltamivir Phosphate
1.2.3 Peramivir
1.2.4 Other Influenza Drugs
1.3 Global Influenza Drugs Market Size by Type
1.3.1 Global Influenza Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Influenza Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Influenza Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Influenza Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Influenza Drugs Sales Breakdown by Type (2018-2023)
2 Global Influenza Drugs Market Competition by Company
2.1 Global Top Players by Influenza Drugs Sales (2018-2023)
2.2 Global Top Players by Influenza Drugs Revenue (2018-2023)
2.3 Global Top Players by Influenza Drugs Price (2018-2023)
2.4 Global Top Manufacturers Influenza Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Influenza Drugs Market Competitive Situation and Trends
2.5.1 Influenza Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Influenza Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Influenza Drugs Market
2.8 Key Manufacturers Influenza Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Influenza Drugs Status and Outlook by Region
3.1 Global Influenza Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Influenza Drugs Historic Market Size by Region
3.2.1 Global Influenza Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Influenza Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Influenza Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Influenza Drugs Forecasted Market Size by Region
3.3.1 Global Influenza Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Influenza Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Influenza Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Influenza Drugs by Application
4.1 Influenza Drugs Market Segment by Application
4.1.1 Adults
4.1.2 Chidren
4.2 Global Influenza Drugs Market Size by Application
4.2.1 Global Influenza Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Influenza Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Influenza Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Influenza Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Influenza Drugs Sales Breakdown by Application (2018-2023)
5 North America Influenza Drugs by Country
5.1 North America Influenza Drugs Historic Market Size by Country
5.1.1 North America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Influenza Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Influenza Drugs Sales in Value by Country (2018-2023)
5.2 North America Influenza Drugs Forecasted Market Size by Country
5.2.1 North America Influenza Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Influenza Drugs Sales in Value by Country (2024-2029)
6 Europe Influenza Drugs by Country
6.1 Europe Influenza Drugs Historic Market Size by Country
6.1.1 Europe Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Influenza Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Influenza Drugs Sales in Value by Country (2018-2023)
6.2 Europe Influenza Drugs Forecasted Market Size by Country
6.2.1 Europe Influenza Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Influenza Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Influenza Drugs by Region
7.1 Asia-Pacific Influenza Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Influenza Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Influenza Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Influenza Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Influenza Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Influenza Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Influenza Drugs Sales in Value by Region (2024-2029)
8 Latin America Influenza Drugs by Country
8.1 Latin America Influenza Drugs Historic Market Size by Country
8.1.1 Latin America Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Influenza Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Influenza Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Influenza Drugs Forecasted Market Size by Country
8.2.1 Latin America Influenza Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Influenza Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Influenza Drugs by Country
9.1 Middle East and Africa Influenza Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Influenza Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Influenza Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Influenza Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Influenza Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Influenza Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Influenza Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb]
10.1.1 Bristol-Myers Squibb] Company Information
10.1.2 Bristol-Myers Squibb] Introduction and Business Overview
10.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
10.1.5 Bristol-Myers Squibb] Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca Influenza Drugs Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Eli Lilly
10.3.1 Eli Lilly Company Information
10.3.2 Eli Lilly Introduction and Business Overview
10.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Eli Lilly Influenza Drugs Products Offered
10.3.5 Eli Lilly Recent Development
10.4 Roche
10.4.1 Roche Company Information
10.4.2 Roche Introduction and Business Overview
10.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Roche Influenza Drugs Products Offered
10.4.5 Roche Recent Development
10.5 GlaxoSmithKline
10.5.1 GlaxoSmithKline Company Information
10.5.2 GlaxoSmithKline Introduction and Business Overview
10.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GlaxoSmithKline Influenza Drugs Products Offered
10.5.5 GlaxoSmithKline Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Introduction and Business Overview
10.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Influenza Drugs Products Offered
10.6.5 Novartis Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Pfizer Influenza Drugs Products Offered
10.7.5 Pfizer Recent Development
10.8 Sanofi Pasteur
10.8.1 Sanofi Pasteur Company Information
10.8.2 Sanofi Pasteur Introduction and Business Overview
10.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sanofi Pasteur Influenza Drugs Products Offered
10.8.5 Sanofi Pasteur Recent Development
10.9 Bayer
10.9.1 Bayer Company Information
10.9.2 Bayer Introduction and Business Overview
10.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Bayer Influenza Drugs Products Offered
10.9.5 Bayer Recent Development
10.10 Celgene
10.10.1 Celgene Company Information
10.10.2 Celgene Introduction and Business Overview
10.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Celgene Influenza Drugs Products Offered
10.10.5 Celgene Recent Development
10.11 Seqirus
10.11.1 Seqirus Company Information
10.11.2 Seqirus Introduction and Business Overview
10.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Seqirus Influenza Drugs Products Offered
10.11.5 Seqirus Recent Development
10.12 Protein Sciences Corporation
10.12.1 Protein Sciences Corporation Company Information
10.12.2 Protein Sciences Corporation Introduction and Business Overview
10.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Protein Sciences Corporation Influenza Drugs Products Offered
10.12.5 Protein Sciences Corporation Recent Development
10.13 Serum Institute of India
10.13.1 Serum Institute of India Company Information
10.13.2 Serum Institute of India Introduction and Business Overview
10.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Serum Institute of India Influenza Drugs Products Offered
10.13.5 Serum Institute of India Recent Development
10.14 Emergent Biosolutions
10.14.1 Emergent Biosolutions Company Information
10.14.2 Emergent Biosolutions Introduction and Business Overview
10.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Emergent Biosolutions Influenza Drugs Products Offered
10.14.5 Emergent Biosolutions Recent Development
10.15 BioCryst Pharmaceuticals
10.15.1 BioCryst Pharmaceuticals Company Information
10.15.2 BioCryst Pharmaceuticals Introduction and Business Overview
10.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 BioCryst Pharmaceuticals Influenza Drugs Products Offered
10.15.5 BioCryst Pharmaceuticals Recent Development
10.16 Alvogen
10.16.1 Alvogen Company Information
10.16.2 Alvogen Introduction and Business Overview
10.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Alvogen Influenza Drugs Products Offered
10.16.5 Alvogen Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Influenza Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Influenza Drugs Industrial Chain Analysis
11.4 Influenza Drugs Market Dynamics
11.4.1 Influenza Drugs Industry Trends
11.4.2 Influenza Drugs Market Drivers
11.4.3 Influenza Drugs Market Challenges
11.4.4 Influenza Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Influenza Drugs Distributors
12.3 Influenza Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer